ABCG2 and breast carcinoma: Surprisingly given its name, relatively little is known about the expression or prognostic value of BCRP in clinical breast cancers, although over-expression has been associated with drug-resistance in many in vitro studies [13], and higher expression has been associated with more advanced disease [14].